Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
15 After 36 weeks of using tirzepatide, patients will be randomly assigned to continue treatment or start using a placebo in the SURMOUNT-4 study, which will seek to determine whether weight loss is maintained for a longer period
GLP-1 medications slow gastric emptying, causing food to remain in the digestive system longer and potentially increasing gas production and sulphur-smelling burps
$7.25 Free Shipping
Retatrutide has shown the highest weight loss numbers in trials so far (28.7% in Phase 3 TRIUMPH-4 vs 22.5% for tirzepatide in SURMOUNT-1 and 15.8% for semaglutide in STEP-1)
A typical patient might lose 12 to 15 percent of their body weight over time
There are also options to deliver the medicines to other countries
